Influence of granulating method on physical and mechanical properties, compression behavior, and compactibility of lactose and microcrystalline cellulose granules

Drug Development and Industrial Pharmacy

Volumn 26, Issue 6, 2000, Pages 583-593

  Horisawa, Eijiro ^a   Danjo, Kazumi ^b   Sunada, Hisakazu ^b  

^a Maruho Co   (Japan)

^b MEIJO UNIVERSITY   (Japan)

Author keywords

Compactibility; Compressibility; Granulating method; Granule strength; Radical tensile strength

Indexed keywords

LACTOSE; MICROCRYSTALLINE CELLULOSE;

ARTICLE; COMPRESSION; DRUG GRANULE; PARTICLE SIZE; PHYSICAL PARAMETERS; TABLET FORMULATION; TENSILE STRENGTH;

CELLULOSE; CHEMISTRY, PHARMACEUTICAL; COMPRESSIVE STRENGTH; LACTOSE; PARTICLE SIZE; TABLETS; TENSILE STRENGTH;

EID: 0034025826     PISSN: 03639045     EISSN: None     Source Type: Journal    
DOI: 10.1081/DDC-100101273     Document Type: Article

References (38)

1. E. Horisawa, M. Yamada, K. Danjo, and A. Otsuka, Yakuzaigaku, 52(1), 13-24 (1992).
2. E. Horisawa, A. Komura, K. Danjo, and A. Otsuka, Chem. Pharm. Bull., 41(8), 1428-1433 (1993).
3. E. Horisawa, A. Komura, K. Danjo, and A. Otsuka, Chem. Pharm. Bull., 43(3), 488-492 (1995).
4. E. Horisawa, A. Komura, K. Danjo, and A. Otsuka, Chem. Pharm. Bull., 43(12), 2261-2263 (1995).
5. J. V. D. Zwan and C. A. M. Sisken, Powder Technol., 33, 43-54 (1982).
6. Y. Kawashima, F. Cui, H. Takeuchi, T. Niwa, T. Hino, and K. Kiuchi, Powder Technol., 78, 151-157 (1994).
7. Y. Kawashima, F. Cui, H. Takeuchi, T. Niwa, T. Hino, and K. Kiuchi, Pharm. Res., 12(7), 1040-1044 (1995).
8. D. J. Train, J. Pharm. Pharmacol., 8, 745-761 (1956).
9. A. B. Selkilk and D. Ganderton, J. Pharm. Pharmacol., 22, 86-94 (1970).
10. D. Ganderson and B. M. Hunter, J. Pharm. Pharmacol., 23(suppl.), 1S-10S (1971).
11. I. Krycer and D. G. Pope, Powder Technol., 33, 101-111 (1982).
12. I. Krycer, D. G. Pope, and J. A. Hersey, Int. J. Pharm., 12, 113-134 (1982).
13. I. Krycer, Drug Dev. Ind. Pharm., 8, 307-342 (1982).
14. M. Veillard, R. Bentejac, F. Puisieuk, and D. Duckene, Int. J. Pharm. Technol. Prod. Manuf., 3, 100-107 (1982).
15. K. Sugimori, Y. Kawashima, H. Takeuchi, T. Hino, T. Niwa, S. Ohno, and S. Mori, J. Soc. Powder Technol., Jpn., 27(9), 30-34 (1990).
16. G. Alderborn, P. O. Lang, A. Sagstrom, and A. Kristensen, Int. J. Pharm., 37, 155-161 (1987).
17. M. Wikberg and G. Alderborn, Int. J. Pharm., 62, 229-241 (1990)
18. M. Wikberg and G. Alderborn, Int. J. Pharm., 63, 23-27 (1990).
19. M. Wikberg and G. Alderborn, Int. J. Pharm., 69, 239-253 (1991).
20. M. Wikberg and G. Alderborn, Int. J. Pharm., 84, 191-195 (1992).
21. M. Eriksson and G. Alderborn, Pharm. Res., 12(7), 1031-1039 (1995).
22. J. N. C. Healey, J. F. Humphreys-Jones, and V. Walters, J. Pharm. Pharmacol., 25, 110S (1973).
23. B. Johansson, M. Wikberg, R. Ek, and G. Alderborn, Int. J. Pharm., 117, 57-73 (1995).
24. K. A. Riepma, H. Vromans, K. Zuurman, and C. F. Lerk, Int. J. Pharm., 97, 29-38 (1993).
25. K. Zuurman, K. A. Riepma, G. K. Bolhuis, H. Vormans, and C. F. Lerk, Int. J. Pharm., 102, 1-9 (1994).
26. B. Pettersson, F. Podczeck, and J. M. Newton, Pharm. Sci., 2, 555-557 (1996).
27. B. Pettersson, F. Podczeck, and J. M. Newton, Pharm. Sci., 3, 329-331 (1997).
28. E. Doelker and E. Shotton, J. Pharm. Pharmacol., 29, 193-198 (1977).
29. P. J. Jarosz and E. L. Parrott, J. Pharm. Sci., 72(5), 530-535 (1983).
30. J. T. Fell and J. M. Newton, J. Pharm. Pharmacol., 20, 657-658 (1968).
31. K. Danjo, K. Kozaki, H. Sunada, and A. Otsuka, Chem. Pharm. Bull., 42, 2121-2125 (1994).
32. K. Danjo, H. Kimura, and A. Otsuka, Drug Dev. Ind. Pharm., 22(9&10), 933-942 (1996).
33. R. W. Heckel, Trans. Metal. Soc. A., 221(11), 1001-1008 (1961).
34. L. Maganti and M. Çelik, Int. J. Pharm., 95, 29-42 (1993).
35. G. Ragnarsson and J. Sjogren, Int. J. Pharm., 12, 163-171 (1982).
36. E. Doelker, D. Mordier, H. Iten, and P. Hambert, Drug Dev. Ind. Pharm., 13, 1847-1875 (1987).
37. T. Pesonen and P. Paronen, Drug Dev. Ind. Pharm., 16, 591-612 (1987).
38. E. Doelker, Drug Dev. Ind. Pharm., 19, 2399-2471 (1993).